| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jari Tiihonen, Tero Hallikainen, Olli-Pekka Ryynänen, Eila Repo-Tiihonen, Irma Kotilainen, Markku Eronen, Päivi Toivonen, Kristian Wahlbeck, Anu Putkone. [Lamotrigine in clozapine treatment-resistant schizophrenia]. Duodecim; laaketieteellinen aikakauskirja. vol 120. issue 1. 2004-07-26. PMID:14976813. |
[lamotrigine in clozapine treatment-resistant schizophrenia]. |
2004-07-26 |
2023-08-12 |
Not clear |
| Andres Gross, Sirkka-Liisa Joutsiniemi, Ranan Rimon, Björn Appelber. Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study. Pharmacopsychiatry. vol 37. issue 3. 2004-07-19. PMID:15138895. |
the changes of theta activity (3.5-7 hz) in the quantitative electroencephalography (qeeg) and serum clozapine levels and their correlation with clinical response, measured by the positive and negative syndrome rating scale (panss) for schizophrenia, were examined prospectively in 16 patients suffering from schizophrenia during 18 weeks of clozapine (clo) treatment. |
2004-07-19 |
2023-08-12 |
Not clear |
| Alessia S Maddalena, Mark Fox, Marc Hofmann, Christoph Hoc. Esophageal dysfunction on psychotropic medication. A case report and literature review. Pharmacopsychiatry. vol 37. issue 3. 2004-07-19. PMID:15138897. |
we report the association of long-term clozapine and clomipramine therapy with severe esophageal dilation and hypomotility in a patient with chronic schizophrenia leading to life threatening aspiration pneumonia. |
2004-07-19 |
2023-08-12 |
Not clear |
| Philip J Tyson, Kate H Roberts, Ann M Mortime. Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors? The International journal of neuroscience. vol 114. issue 6. 2004-07-19. PMID:15204055. |
forty-four patients with a dsm-iv diagnosis of schizophrenia were recruited within 6 weeks of starting one of the atypical antipsychotics: clozapine, olanzapine, risperidone, quetiapine, or amisulpride. |
2004-07-19 |
2023-08-12 |
Not clear |
| Carrie L Ernst, Joseph F Goldber. Antisuicide properties of psychotropic drugs: a critical review. Harvard review of psychiatry. vol 12. issue 1. 2004-07-15. PMID:14965852. |
nevertheless, an extensive literature has arisen regarding observed reductions in suicidal behavior with lithium for mood disorders and, to a lesser extent, with clozapine for schizophrenia. |
2004-07-15 |
2023-08-12 |
Not clear |
| John M Davis, Nancy Che. Dose response and dose equivalence of antipsychotics. Journal of clinical psychopharmacology. vol 24. issue 2. 2004-07-06. PMID:15206667. |
doses of clozapine well above 400 mg are necessary for optimal treatment of many schizophrenia patients. |
2004-07-06 |
2023-08-12 |
Not clear |
| Jan Volavka, Pal Czobor, Karen Nolan, Brian Sheitman, Jean-Pierre Lindenmayer, Leslie Citrome, Joseph P McEvoy, Thomas B Cooper, Jeffrey A Lieberma. Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. Journal of clinical psychopharmacology. vol 24. issue 2. 2004-07-06. PMID:15206671. |
overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. |
2004-07-06 |
2023-08-12 |
human |
| Rocco Zoccali, Maria Rosaria Muscatello, Clemente Cedro, Pietro Neri, Diletta La Torre, Edoardo Spina, Antonio Enrico Di Rosa, Mario Medur. The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study. International clinical psychopharmacology. vol 19. issue 2. 2004-06-22. PMID:15076014. |
the effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study. |
2004-06-22 |
2023-08-12 |
Not clear |
| Rocco Zoccali, Maria Rosaria Muscatello, Clemente Cedro, Pietro Neri, Diletta La Torre, Edoardo Spina, Antonio Enrico Di Rosa, Mario Medur. The effect of mirtazapine augmentation of clozapine in the treatment of negative symptoms of schizophrenia: a double-blind, placebo-controlled study. International clinical psychopharmacology. vol 19. issue 2. 2004-06-22. PMID:15076014. |
this study was a 8-week double-blind, randomized, placebo-controlled trial of 30 mg adjunctive mirtazapine to clozapine therapy in 24 patients with dsm-iv schizophrenia. |
2004-06-22 |
2023-08-12 |
Not clear |
| Péter Gaszner, Zoltán Makko. Clozapine maintenance therapy in schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 28. issue 3. 2004-06-17. PMID:15093952. |
clozapine maintenance therapy in schizophrenia. |
2004-06-17 |
2023-08-12 |
Not clear |
| Péter Gaszner, Zoltán Makko. Clozapine maintenance therapy in schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 28. issue 3. 2004-06-17. PMID:15093952. |
records from over 1000 patients treated with clozapine during the past 22 years were examined; 782 of these patients were diagnosed with schizophrenia according to the diagnostic and statistical manual of mental disorders-fourth edition-text revision (dsm-iv-tr) criteria (with the modification in early years). |
2004-06-17 |
2023-08-12 |
Not clear |
| Péter Gaszner, Zoltán Makko. Clozapine maintenance therapy in schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 28. issue 3. 2004-06-17. PMID:15093952. |
clozapine administered for long-term maintenance therapy was effective both in paranoid and in catatonic schizophrenia. |
2004-06-17 |
2023-08-12 |
Not clear |
| Rocco Zoccali, Maria Rosaria Muscatello, Diletta La Torre, Giovanni Malara, Andrea Canale, Domenico Crucitti, Concetta D'Arrigo, Edoardo Spin. Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia. Pharmacological research. vol 48. issue 4. 2004-06-16. PMID:12902213. |
lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia. |
2004-06-16 |
2023-08-12 |
Not clear |
| Rocco Zoccali, Maria Rosaria Muscatello, Diletta La Torre, Giovanni Malara, Andrea Canale, Domenico Crucitti, Concetta D'Arrigo, Edoardo Spin. Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia. Pharmacological research. vol 48. issue 4. 2004-06-16. PMID:12902213. |
the effect of mirtazapine on steady-state plasma concentrations of the newer atypical antipsychotics clozapine, risperidone and olanzapine was investigated in 24 patients with chronic schizophrenia. |
2004-06-16 |
2023-08-12 |
Not clear |
| b' Agnieszka Basta-Kaim, Bogus\\xc5\\x82awa Budziszewska, Lucylla Jaworska-Feil, Monika Le\\xc5\\x9bkiewicz, Magdalena Tetich, Marta Kubera, Simon Scharpe, W\\xc5\\x82adys\\xc5\\x82aw Laso\\xc5\\x8. Opposite effects of clozapine and sulpiride on the lipopolysaccharide-induced inhibition of the GR-mediated gene transcription in fibroblast cells. Polish journal of pharmacology. vol 55. issue 6. 2004-06-15. PMID:14730115.' |
opposite effect of clozapine and sulpiride on lps action may result from their distinct effect on activity of some kinases involved in regulation of gr transcriptional function and may determine their utility in the treatment of schizophrenia with or without immune system activation. |
2004-06-15 |
2023-08-12 |
mouse |
| Marcus W Agelink, Ilker Kavuk, Ismail A. Clozapine with amisulpride for refractory schizophrenia. The American journal of psychiatry. vol 161. issue 5. 2004-06-03. PMID:15121665. |
clozapine with amisulpride for refractory schizophrenia. |
2004-06-03 |
2023-08-12 |
Not clear |
| Laura Dazzi, Emanuele Seu, Giulia Cherchi, Giovanni Biggi. Inhibition of stress-induced dopamine output in the rat prefrontal cortex by chronic treatment with olanzapine. Biological psychiatry. vol 55. issue 5. 2004-05-27. PMID:15023575. |
evidence suggests that treatment with the atypical antipsychotic drugs olanzapine or clozapine results in a superior amelioration of the anxious and depressive symptoms that accompany schizophrenia relative to therapy with classical antipsychotics such as haloperidol. |
2004-05-27 |
2023-08-12 |
rat |
| Lilly Schwieler, Göran Engberg, Sophie Erhard. Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex. Synapse (New York, N.Y.). vol 52. issue 2. 2004-05-21. PMID:15034917. |
the inhibitory action of clozapine on vta da neurons may account for its beneficial effects in ameliorating symptoms of schizophrenia and may suggest further studies to investigate a role of the glycine site of the nmda receptor as a target for novel antipsychotics. |
2004-05-21 |
2023-08-12 |
rat |
| Stephen Layton, Martin Barbea. Generic replacement of clozapine: a simple decision model from a Canadian perspective. Current medical research and opinion. vol 20. issue 4. 2004-05-21. PMID:15119982. |
the difference at reported upon switching patients with schizophrenia from brand name to generic clozapine. |
2004-05-21 |
2023-08-12 |
Not clear |
| A Pérez Bravo, M A Puña. [Sleep disorders with antipsychotic drugs: based on one case with clozapine]. Actas espanolas de psiquiatria. vol 32. issue 2. 2004-05-11. PMID:15042472. |
clozapine is a widely used atypical neuroleptic in the treatment of schizophrenia; its effects on sleep have been poorly studied, sedation being one of its side effects. |
2004-05-11 |
2023-08-12 |
Not clear |